Management of patients with recurrent vulvovaginal candidiasis

Drugs

Volumn 63, Issue 11, 2003, Pages 1059-1066

  Sobel, Jack D ^a,b  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HARPER UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BORIC ACID; ESTROGEN; FLUCONAZOLE; FLUCYTOSINE; KETOCONAZOLE; MEDROXYPROGESTERONE ACETATE; NYSTATIN; ORAL CONTRACEPTIVE AGENT; PYRROLE DERIVATIVE; YOGHURT;

CANDIDA ALBICANS; CANDIDA GLABRATA; CLINICAL FEATURE; CLINICAL TRIAL; DESENSITIZATION; DIFFERENTIAL DIAGNOSIS; DRUG EFFICACY; FEMALE; HORMONE SUBSTITUTION; HUMAN; INCIDENCE; MAINTENANCE THERAPY; MICROBIOLOGICAL EXAMINATION; ORAL CONTRACEPTION; PATHOGENESIS; RECURRENT INFECTION; REVIEW; VAGINA CANDIDIASIS;

ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDA GLABRATA; CANDIDIASIS, VULVOVAGINAL; FEMALE; HUMANS; RECURRENCE;

CANDIDA; CANDIDA ALBICANS; CANDIDA GLABRATA;

EID: 0038282386     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200363110-00002     Document Type: Review

References (24)

1. Sobel JD. Epidemiology and pathogenesis of recurrent vulvovaginal candidiasis. Am J Obstet Gynecol 1985; 152: 924-35
2. Foxman B, Marsh JV, Gillespie B, et al. Frequency and response to vaginal symptoms among white and black women: results of a random digital dialing survey. J Womens Health 1998; 7: 1167-74
3. Sobel JD, Faro S, Force RW, et al. Vulvovaginal candidiasis: epidemiologic, diagnostic, and therapeutic considerations. Am J Obstet Gynecol 1998; 178: 203-11
4. Sobel JD, Kapernik P, Zervos M, et al. Treatment of complicated Candida vaginitis: comparison of single and sequential doses of fluconazole. Am J Obstet Gynecol 2001; 185: 363-9
5. Lynch ME, Sobel JD. Comparative in vitro activity of antimycotic against pathogenic vaginal yeast isolates. J Med Vet Mycol 1994; 32: 267-74
6. Vazquez JA, Sobel JD, Demitriou R, et al. Karotyping of C. albicans obtained longitudinally in women with recurrent vulvovaginal candidiasis. J Infect Dis 1994; 170: 1566-9
7. Sobel JD. Pathogenesis of recurrent vulvovaginal candidiasis. Curr Infect Dis Rep 2002; 4: 514-9
8. Fidel Jr PL, Sobel JD. Immunopathogenesis of recurrent vulvovaginal candidiasis. Clin Microbiol Rev 1996; 9: 335-48
9. Sobel JD. Recurrent vulvovaginal candidiasis: a prospective study of the efficacy of maintenance ketoconazole therapy. N Engl J Med 1986; 315: 1455-8
10. Sobel JD. Fluconazole maintenance therapy in recurrent vulvovaginal candidiasis. Int J Gynecol Obstet 1992; 37: 17-34
11. Houang ET, Chappatte O, Byrne D, et al. Fluconazole levels in plasma and vaginal secretions of patients with the 150mg single does and rate of eradication of infections in vaginal candidiasis. Antimicrob Agents Chemother 1990; 34: 909-13
12. Ritter W. Pharmacokinetics fundamentals of vaginal treatment with clotrimazole. Am J Obstet Gynecol 1985; 152: 945-7
13. Davidson F, Mould RF. Recurrent genital candidosis in women and the effect of intermittent prophylactic treatment. Br J Vener Dis 1978; 54: 176-83
14. Stein GE, Mummau ML, Schooky SL. Prevention of recurrence vaginal candidiasis with weekly terconazole cream. Ann Pharmacother 1996; 30: 1080-3
15. Tooley PJ. Patient and doctor preference in the treatment of vaginal candidiasis. Practitioner 1985; 229: 655-60
16. Fong IW. The value of treating the sexual partners of women with recurrent vaginal candidiasis with ketoconazole. Genitourin Med 1992; 68: 174-6
17. Spinillo A, Carratta L, Pizzoli G, et al. Recurrent vaginal candidiasis: results of a cohort study of sexual transmission and intestinal reservoir. J Reprod Med 1992; 37: 343-7
18. Dennerstein GJ. Depo-Provera in the treatment of recurrent vulvovaginal candidiasis. J Reprod Med 1986; 31: 801-3
19. Hilton E, Isenberg HD, Alperstein P, et al. Ingestion of yogurt containing Lactobacillus acidophilus as prophylaxis for candidal vaginitis. Ann Intern Med 1992; 116: 353-7
20. Rosedale N, Braue K. Hyposensitization in the management of recurring vaginal candidiasis. Ann Allergy 1979; 43: 250-3
21. Rigg D, Miller MM, Metzger WJ. Recurrent allergic vulvovaginitis treatment with Candida albicans allergen immunotherapy. Am J Obstet Gynecol 1990; 162: 332-9
22. Sobel JD, Chaim W. Therapy of T. glabrata vaginitis: retrospective review of boric acid therapy. Clin Infect Dis 1997; 24: 649-52
23. Sobel JD, Ohmit SE, Schuman P, et al. The evolution of Candida species and fluconazole susceptibility among oral and vaginal isolates recovered from HIV-seropositive and at-risk seronegative women. J Infect Dis 2001; 182: 286-93
24. Schuman P, Capps L, Peng G, et al. Prevention of mucosal candidiasis in women infected with the human immunodeficiency virus (HIV): a randomized, double-blind study comparing weekly fluconazole prophylaxis with placebo. Ann Intern Med 1997; 126: 689-96